Contraindicated in:
Use Cautiously in:
Drug-drug:
Therapeutic Classification: hereditary angioedema agents
Pharmacologic Classification: bradykinin B2 receptor antagonists
(reduction of symptoms)
| ROUTE | ONSET | PEAK | DURATION |
|---|---|---|---|
| SUBQ | within 1 hr | 2.02.6 hr‡ | 68 hr |
‡50% reduction in baseline symptoms.
NDC Code